Encompass Health (EHC) Receives a Buy from TD Cowen

Encompass Health received a Buy rating and a $125.00 price target from TD Cowen analyst Ryan Langston today.

Memorial Day Sale – Claim 70% Off TipRanks

• Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
• Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Langston covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Astrana Health, and Surgery Partners. According to TipRanks, Langston has an average return of -5.7% and a 36.09% success rate on recommended stocks.

Currently, the analyst consensus on Encompass Health is a Strong Buy with an average price target of $138.00.

Based on Encompass Health’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.59 billion and a net profit of $194.5 million. In comparison, last year the company earned a revenue of $1.46 billion and had a net profit of $151.5 million

Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EHC in relation to earlier this year. Earlier this month, Douglas Coltharp, the EVP & CFO of EHC sold 27,694.00 shares for a total of $2,958,550.47.